RB Global Investing Cash Flow increased by 10.0% to -$78.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.7%, from -$101.90M to -$78.80M. Over 3 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 37.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$13.27M | -$9.07M | -$181.72M | $154.90M | -$2.82B | -$69.50M | -$109.80M | -$106.00M | -$77.50M | -$54.20M | -$77.90M | -$92.00M | -$101.90M | -$126.00M | -$237.40M | -$87.60M | -$78.80M |
| QoQ Change | — | +31.6% | <-999% | +185.2% | <-999% | +97.5% | -58.0% | +3.5% | +26.9% | +30.1% | -43.7% | -18.1% | -10.8% | -23.7% | -88.4% | +63.1% | +10.0% |
| YoY Change | — | — | — | — | <-999% | — | — | — | +97.3% | +22.0% | +29.1% | +13.2% | -31.5% | -132.5% | -204.7% | +4.8% | +22.7% |